
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
General Description:
The Manager, Distribution & Regional Quality, Europe Quality is responsible for overseeing Good Manufacturing Practices (GMP) as well as Good Distribution Practice (GDP) operations related to the commercial products including trading in foreign countries.
This position ensures compliance with EU GMP and GDP regulations on transportation, wholesale and distribution as well as adherence to EU regulations and to French regulation applicable to exploitant facility (French health code, local french GMP/GDP; and HAS (Haute Autorité de Santé) certification for promotional activities) as well as BeOne's internal quality processes and procedures.
BeOne operates several affiliates in Europe and holds different GxP licenses in these affiliates. The job incumbent will execute the assigned activities on behalf of the below listed affiliates based on the license utilized.
Affiliates in scope: BeOne Medicines France Sarl, BeOne Medicines I GmbH, BeOne Medicines I GmbH, Dutch Branch, BeOne Medicines UK, Ltd and BeOne Medicines Germany GmbH
For activities performed for Switzerland under BeOne Medicines I GmbH the allowed delegations per VV-QDOC-10970 CH – Deputization and Delegation of RP Tasks within BeiGene Switzerland GmbH apply.
Essential Functions of the job:
Education Required:
Computer Skills:
Core Knowledge and Skill Requirements
Other Qualifications:
Travel:
Salary Range France: 60,200.00 EUR - 75,300.00 EUR
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.